Skip to Main Content

Hello, everyone, and how are you today? We are doing just fine, thank you, despite gloomy skies and chilly temperatures enveloping the Pharmalot campus. After all, as the recently departed Morning Mayor used to say: Every day should be unwrapped like a precious gift. And why not? On that note, time to get on with things. There is much to do, yes? So to help you on your way, here are a few items of interest. We hope you conquer the world today and, of course, please do keep us in mind when something saucy arises.

Sanofi (SNY) was charged by French authorities for failing to adequately warn patients about the risks of its Depakote epilepsy drug, which has been linked to birth defects, Reuters writes. The charges follow a three-year probe into the company, which was launched in September 2016 following legal action by victims and their families as they sought to determine whether Sanofi misled doctors and patients. Studies found that the babies of women who took the medicine while pregnant had a 10% elevated risk for congenital malformations.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!